Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning
Authors
Keywords
-
Journal
Molecular Oncology
Volume 10, Issue 1, Pages 85-100
Publisher
Wiley
Online
2015-08-22
DOI
10.1016/j.molonc.2015.07.006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DNA Methylation of DKK3 Modulates Docetaxel Chemoresistance in Human Nonsmall Cell Lung Cancer Cell
- (2015) Leilei Tao et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Design and Synthesis of New α-Naphthoflavones as Cytochrome P450 (CYP) 1B1 Inhibitors To Overcome Docetaxel-Resistance Associated with CYP1B1 Overexpression
- (2015) Jiahua Cui et al. JOURNAL OF MEDICINAL CHEMISTRY
- miR-141 confers docetaxel chemoresistance of breast cancer cells via regulation of EIF4E expression
- (2015) YA-SAI YAO et al. ONCOLOGY REPORTS
- Acquisition of docetaxel resistance in breast cancer cells reveals upregulation of ABCB1 expression as a key mediator of resistance accompanied by discrete upregulation of other specific genes and pathways
- (2015) Stine Ninel Hansen et al. TUMOR BIOLOGY
- Serum exosomal P-glycoprotein is a potential marker to diagnose docetaxel resistance and select a taxoid for patients with prostate cancer
- (2015) Taku Kato et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Use of Formalin-Fixed Paraffin-Embedded Samples for Gene Expression Studies in Breast Cancer Patients
- (2015) Valeria Musella et al. PLoS One
- Inhibition of Survivin Restores the Sensitivity of Breast Cancer Cells to Docetaxel and Vinblastine
- (2014) Parisa Ghanbari et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- Evaluation of an integrated clinical workflow for targeted next-generation sequencing of low-quality tumor DNA using a 51-gene enrichment panel
- (2014) Ashish Choudhary et al. BMC Medical Genomics
- Abcc10 status affects mammary tumour growth, metastasis and docetaxel treatment response
- (2014) N Domanitskaya et al. BRITISH JOURNAL OF CANCER
- Survivin Expression as a Prognostic Factor in Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer Treated With Neoadjuvant Chemotherapy
- (2014) Agnieszka Gąsowska-Bodnar et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- A 20-gene signature in predicting the chemoresistance of breast cancer to taxane-based chemotherapy
- (2014) Dong-Xu He et al. Molecular BioSystems
- Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies
- (2014) Y Aye et al. ONCOGENE
- Establishment of human pancreatic cancer gemcitabine-resistant cell line with ribonucleotide reductase overexpression
- (2014) CONGFEI WANG et al. ONCOLOGY REPORTS
- PharmGKB summary
- (2014) Maria L. Alvarellos et al. Pharmacogenetics and Genomics
- MicroRNA-452 contributes to the docetaxel resistance of breast cancer cells
- (2014) Qing Hu et al. TUMOR BIOLOGY
- Splicing mutation analysis reveals previously unrecognized pathways in lymph node-invasive breast cancer
- (2014) Stephanie N. Dorman et al. Scientific Reports
- nab-Paclitaxel for first-line treatment of patients with metastatic breast cancer and poor prognostic factors: a retrospective analysis
- (2013) Joyce O’Shaughnessy et al. BREAST CANCER RESEARCH AND TREATMENT
- Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes
- (2013) Aleix Prat et al. BREAST CANCER RESEARCH AND TREATMENT
- Genetic polymorphisms of SLC28A3, SLC29A1 and RRM1 predict clinical outcome in patients with metastatic breast cancer receiving gemcitabine plus paclitaxel chemotherapy
- (2013) Soo-Youn Lee et al. EUROPEAN JOURNAL OF CANCER
- Prostate apoptosis response-4 is involved in the apoptosis response to docetaxel in MCF-7 breast cancer cells
- (2013) MICHELLY C. PEREIRA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- TLR agonists: our best frenemy in cancer immunotherapy
- (2013) Sabina Kaczanowska et al. JOURNAL OF LEUKOCYTE BIOLOGY
- TLR4 Is a Novel Determinant of the Response to Paclitaxel in Breast Cancer
- (2013) S. Rajput et al. MOLECULAR CANCER THERAPEUTICS
- Modeling precision treatment of breast cancer
- (2013) Anneleen Daemen et al. GENOME BIOLOGY
- Interpretation, Stratification and Evidence for Sequence Variants Affecting mRNA Splicing in Complete Human Genome Sequences
- (2013) Ben C. Shirley et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) F. Cardoso et al. ANNALS OF ONCOLOGY
- Structural and genic characterization of stable genomic regions in breast cancer: Relevance to chemotherapy
- (2012) Nicole I. Park et al. Molecular Oncology
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Tau expression correlated with breast cancer sensitivity to taxanes-based neoadjuvant chemotherapy
- (2012) Kun Wang et al. TUMOR BIOLOGY
- RRM2B Suppresses Activation of the Oxidative Stress Pathway and is Up-regulated by P53 During Senescence
- (2012) Mei-Ling Kuo et al. Scientific Reports
- Paclitaxel sensitivity of breast cancer cells requires efficient mitotic arrest and disruption of Bcl-xL/Bak interaction
- (2011) M. Luz Flores et al. BREAST CANCER RESEARCH AND TREATMENT
- Phosphorylation of Serine 68 of Twist1 by MAPKs Stabilizes Twist1 Protein and Promotes Breast Cancer Cell Invasiveness
- (2011) J. Hong et al. CANCER RESEARCH
- A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer
- (2011) Christos Hatzis JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of palliative chemotherapy for patients with advanced breast cancer pretreated with anthracyclines and taxanes: a systematic review
- (2011) Linda JM Oostendorp et al. LANCET ONCOLOGY
- Metastasis-suppressor genes in clinical practice: lost in translation?
- (2011) Alexander N. Shoushtari et al. Nature Reviews Clinical Oncology
- Do Two Machine-Learning Based Prognostic Signatures for Breast Cancer Capture the Same Biological Processes?
- (2011) Yotam Drier et al. PLoS One
- A Novel Requirement for Janus Kinases as Mediators of Drug Resistance Induced by Fibroblast Growth Factor-2 in Human Cancer Cells
- (2011) Catarina R. Carmo et al. PLoS One
- Subtype and pathway specific responses to anticancer compounds in breast cancer
- (2011) L. M. Heiser et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome
- (2011) David Venet et al. PLoS Computational Biology
- Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3
- (2009) Rajgopal Govindarajan et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- On reliable discovery of molecular signatures
- (2009) Roland Nilsson et al. BMC BIOINFORMATICS
- Thymidylate synthetase allelic imbalance in clear cell renal carcinoma
- (2009) Davide Colavito et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Paclitaxel Directly Binds to Bcl-2 and Functionally Mimics Activity of Nur77
- (2009) C. Ferlini et al. CANCER RESEARCH
- Mitotic Deregulation by Survivin in ErbB2-Overexpressing Breast Cancer Cells Contributes to Taxol Resistance
- (2009) J. Lu et al. CLINICAL CANCER RESEARCH
- SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions
- (2009) Saskia Preissner et al. NUCLEIC ACIDS RESEARCH
- Taxane pathway
- (2009) Connie Oshiro et al. Pharmacogenetics and Genomics
- Tau expression and efficacy of paclitaxel treatment in metastatic breast cancer
- (2008) Satoru Tanaka et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Nuclear receptor mediated induction of cytochrome P450 3A4 by anticancer drugs: a key role for the pregnane X receptor
- (2008) S. Harmsen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Activation of fibronectin/PI-3K/Akt2 leads to chemoresistance to docetaxel by regulating survivin protein expression in ovarian and breast cancer cells
- (2008) Hui Xing et al. CANCER LETTERS
- Alteration of the Mitochondrial Apoptotic Pathway Is Key to Acquired Paclitaxel Resistance and Can Be Reversed by ABT-737
- (2008) O. Kutuk et al. CANCER RESEARCH
- Human Multidrug Resistance Protein 7 (ABCC10) Is a Resistance Factor for Nucleoside Analogues and Epothilone B
- (2008) E. Hopper-Borge et al. CANCER RESEARCH
- Tumour-promoting activity of altered WWP1 expression in breast cancer and its utility as a prognostic indicator
- (2008) NS Nguyen Huu et al. JOURNAL OF PATHOLOGY
- Taxanes, microtubules and chemoresistant breast cancer
- (2007) Barbara T. McGrogan et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started